Houwen Lin Selected Research

stichoposide

1/2022

Stichoposide C Exerts Anticancer Effects on Ovarian Cancer by Inducing Autophagy via Inhibiting AKT/mTOR Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Houwen Lin Research Topics

Disease

7	Neoplasms (Cancer) 02/2022 - 10/2013
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2018
2	Carcinogenesis 01/2022 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2017
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2018 - 07/2017
1	Heart Failure 11/2022
1	Pathologic Processes 02/2022
1	Ovarian Epithelial Carcinoma 01/2022
1	Stomach Neoplasms (Stomach Cancer) 11/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Insulin Resistance 11/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 12/2018
1	Infections 05/2018
1	Chronic Hepatitis C 05/2018
1	Acute Coronary Syndrome 01/2018
1	Stroke (Strokes) 01/2018
1	Hemorrhage 01/2018
1	Inflammation (Inflammations) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Myocardial Infarction 01/2018
1	Pulmonary Arterial Hypertension 11/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2017
1	Disease Progression 11/2017
1	Macular Degeneration (Age-Related Maculopathy) 01/2016
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 10/2013
1	Glioblastoma (Glioblastoma Multiforme) 10/2013
1	Hypoxia (Hypoxemia) 06/2010
1	Ischemia 06/2010

Drug/Important Bio-Agent (IBA)

4	Biological ProductsIBA 02/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 11/2022 - 01/2022
2	TriterpenesIBA 01/2022 - 10/2013
2	EnzymesIBA 01/2022 - 11/2021
2	GlycosidesIBA 01/2022 - 10/2013
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2017
2	SaponinsIBA 10/2013 - 06/2010
1	NAD (NADH)IBA 02/2022
1	CytokinesIBA 02/2022
1	Hormones (Hormone)IBA 01/2022
1	stichoposideIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 11/2021
1	IsomerasesIBA 11/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	LigandsIBA 01/2021
1	Death Domain ReceptorsIBA 01/2021
1	PeptidomimeticsIBA 01/2021
1	BerberineIBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	Volatile Fatty AcidsIBA 11/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2019
1	GlucosidasesIBA 11/2019
1	butyrolactone IIBA 11/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 11/2019
1	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 12/2018
1	MDL-800IBA 12/2018
1	daclatasvirIBA 05/2018
1	InterferonsIBA 05/2018
1	Ribavirin (Virazole)FDA LinkGeneric 05/2018
1	asunaprevirIBA 05/2018
1	Clopidogrel (Plavix)FDA Link 01/2018
1	TicagrelorIBA 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018
1	smenospongineIBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	Angiotensin Receptor AntagonistsIBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 07/2017
1	nilotinib FDA Link 07/2017
1	Dasatinib (BMS 354825)FDA Link 07/2017
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2016
1	Ranibizumab (Lucentis)FDA Link 01/2016
1	Bevacizumab (Avastin)FDA Link 01/2016
1	Verteporfin (Visudyne)FDA Link 01/2016
1	CaspasesIBA 10/2013
1	bryostatin 5IBA 10/2013
1	SteroidsIBA 10/2013

Therapy/Procedure

3	Therapeutics 01/2021 - 05/2018
2	Drug Therapy (Chemotherapy) 11/2017 - 10/2013
1	Photochemotherapy (Photodynamic Therapy) 01/2016